Tibet Rhodiola Pharmaceutical Holding Co (600211) — Long-term Investment Intensity
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Long-term Investment Intensity of 2.9% as of December 2019. Long-term investments of CN¥80.81 Million represent 2.9% of total assets of CN¥2.77 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 600211 net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Tibet Rhodiola Pharmaceutical Holding Co Long-term Investment Intensity (2015–2019)
This chart shows how Tibet Rhodiola Pharmaceutical Holding Co's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 2.9%, reflecting long-term investments of CN¥80.81 Million against total assets of CN¥2.77 Billion CNY. Also explore total assets of Tibet Rhodiola Pharmaceutical Holding Co for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Tibet Rhodiola Pharmaceutical Holding Co (2015–2019)
The table below presents the year-by-year Long-term Investment Intensity for Tibet Rhodiola Pharmaceutical Holding Co from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Tibet Rhodiola Pharmaceutical Holding Co.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.9% | CN¥80.81 Million | CN¥2.77 Billion | ▼ -0.4 pp |
| 2018 | 3.3% | CN¥83.49 Million | CN¥2.53 Billion | ▼ -1.4 pp |
| 2017 | 4.7% | CN¥110.38 Million | CN¥2.33 Billion | ▼ -0.3 pp |
| 2016 | 5.0% | CN¥114.62 Million | CN¥2.29 Billion | ▲ +0.2 pp |
| 2015 | 4.8% | CN¥34.24 Million | CN¥706.33 Million | — |